SPECTRAL AI, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
SPECTRAL AI, INC. (MDAI) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 19.25 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-11
- SPECTRAL AI, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 17.60M shares, a 66.42% increase year-over-year.
- SPECTRAL AI, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 10.57M shares, a 16.05% decline year-over-year.
- SPECTRAL AI, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 12.59M shares, a 179.04% increase year-over-year.
- SPECTRAL AI, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 4.51M shares.
- SPECTRAL AI, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 17.81M shares, a 45.11% increase from fiscal 2024.
- SPECTRAL AI, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 12.27M shares, a 1.05% increase from fiscal 2023.
- SPECTRAL AI, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 12.14M shares, a 167.08% increase from fiscal 2022.
- SPECTRAL AI, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 4.55M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | 19.25M shares 10-Q · filed 2026-08-11 | |||||
| 2026-03-31 | 17.60M shares 10-Q · filed 2026-05-13 | |||||
| 2025-12-31 | 17.81M shares 10-K · filed 2026-03-25 | |||||
| 2025-09-30 | 14.27M shares 10-Q · filed 2025-11-13 | |||||
| 2025-06-30 | 16.82M shares 10-Q · filed 2026-08-11 | 15.81M shares 10-Q · filed 2025-08-13 | ||||
| 2025-03-31 | 10.57M shares 10-Q · filed 2026-05-13 | |||||
| 2024-12-31 | 12.27M shares 10-K · filed 2026-03-25 | 12.27M shares 10-K · filed 2025-03-31 | ||||
| 2024-09-30 | 12.76M shares 10-Q · filed 2025-11-13 | |||||
| 2024-06-30 | 12.91M shares 10-Q · filed 2025-08-13 | |||||
| 2024-03-31 | 12.59M shares 10-Q · filed 2025-05-15 | |||||
| 2023-12-31 | 12.14M shares 10-K · filed 2025-03-31 | |||||
| 2023-09-30 | 13.08M shares 10-Q · filed 2024-11-06 | |||||
| 2023-06-30 | 4.76M shares 10-Q · filed 2024-08-12 | 49.30M shares 8-K · filed 2023-09-15 | ||||
| 2023-03-31 | 4.51M shares 10-Q · filed 2024-05-09 | |||||
| 2022-12-31 | 4.55M shares 10-K · filed 2024-03-29 | |||||
| 2022-09-30 | 4.55M shares 10-Q · filed 2023-11-14 | |||||
| 2022-06-30 | 47.61M shares 8-K · filed 2023-09-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |